APA (7th ed.) Citation

Goto, K., Endo, M., Kusumoto, M., Yamamoto, N., Ohe, Y., Shimizu, A., & Fukuoka, M. (2016). Bevacizumab for non‐small‐cell lung cancer: A nested case control study of risk factors for hemoptysis. Cancer science, 107(12), 1837-1842. https://doi.org/10.1111/cas.13096

Chicago Style (17th ed.) Citation

Goto, Koichi, Masahiro Endo, Masahiko Kusumoto, Nobuyuki Yamamoto, Yuichiro Ohe, Ayaka Shimizu, and Masahiro Fukuoka. "Bevacizumab for Non‐small‐cell Lung Cancer: A Nested Case Control Study of Risk Factors for Hemoptysis." Cancer Science 107, no. 12 (2016): 1837-1842. https://doi.org/10.1111/cas.13096.

MLA (9th ed.) Citation

Goto, Koichi, et al. "Bevacizumab for Non‐small‐cell Lung Cancer: A Nested Case Control Study of Risk Factors for Hemoptysis." Cancer Science, vol. 107, no. 12, 2016, pp. 1837-1842, https://doi.org/10.1111/cas.13096.